David T. Doherty net worth and biography

David Doherty Biography and Net Worth

Dave Doherty was appointed Chief Financial Officer of Surgery Partners, Inc. in February 2022. Prior to this, Mr. Doherty was Surgery Partners’ Senior Vice President of Corporate Finance and Controller. Prior to joining Surgery Partners in 2018, Mr. Doherty held various senior financial management roles at Aetna Inc., including leading Aetna’s internal audit organization, planning and risk management, and serving as Aetna’s assistant controller. Mr. Doherty earned his CPA while working at Arthur Andersen, LLP.

What is David T. Doherty's net worth?: The estimated net worth of David T. Doherty is at least $1.89 million as of February 12th, 2024. Mr. Doherty owns 74,209 shares of Surgery Partners stock worth more than $1,892,330 as of April 25th. This net worth approximation does not reflect any other investments that Mr. Doherty may own. Additionally, Mr. Doherty receives an annual salary of $1,030,000.00 as CFO at Surgery Partners. Learn More about David T. Doherty's net worth.
How old is David T. Doherty?: Mr. Doherty is currently 52 years old. There are 7 older executives and no younger executives at Surgery Partners. The oldest executive at Surgery Partners is Mr. Wayne Scott DeVeydt, Executive Chairman, who is 54 years old. Learn More on David T. Doherty's age.
What is David T. Doherty's salary?: As the CFO of Surgery Partners, Inc., Mr. Doherty earns $1,030,000.00 per year. There are 2 executives that earn more than Mr. Doherty. The highest earning executive at Surgery Partners is Mr. J. Eric Evans, CEO & Director, who commands a salary of $1,450,000.00 per year. Learn More on David T. Doherty's salary.
How do I contact David T. Doherty?: The corporate mailing address for Mr. Doherty and other Surgery Partners executives is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. Surgery Partners can also be reached via phone at (615) 234-5900 and via email at [email protected]. Learn More on David T. Doherty's contact information.
Has David T. Doherty been buying or selling shares of Surgery Partners?: David T. Doherty has not been actively trading shares of Surgery Partners over the course of the past ninety days. Most recently, David T. Doherty sold 1,020 shares of the business's stock in a transaction on Monday, February 12th. The shares were sold at an average price of $34.93, for a transaction totalling $35,628.60. Following the completion of the sale, the chief financial officer now directly owns 74,209 shares of the company's stock, valued at $2,592,120.37. Learn More on David T. Doherty's trading history.
Who are Surgery Partners' active insiders?: Surgery Partners' insider roster includes Jennifer Baldock (Insider), Harrison Bane (President of the American Group), Marissa Brittenham (Chief Strategy Officer), Laura Brocklehurst (Insider), Danielle Burkhalter (Chief Human Resources Officer), Thomas Cowhey (CFO), Teresa DeLuca (Director), Wayne DeVeydt (Chairman), David Doherty (CFO), Jason Evans (CEO), George Goodwin (Insider), Andrew Kaplan (Director), Bradley Owens (National Group President), Anthony Taparo (Insider), and Brent Turner (Director). Learn More on Surgery Partners' active insiders.
Are insiders buying or selling shares of Surgery Partners?: During the last twelve months, insiders at the sold shares 15 times. They sold a total of 8,031,894 shares worth more than $268,619,881.64. The most recent insider tranaction occured on March, 13th when CEO Jason Eric Evans sold 4,840 shares worth more than $143,796.40. Insiders at Surgery Partners own 2.6% of the company. Learn More about insider trades at Surgery Partners.
Information on this page was last updated on 3/13/2024.

David T. Doherty Insider Trading History at Surgery Partners

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/12/2024	Sell	1,020	$34.93	$35,628.60	74,209
2/2/2024	Sell	2,306	$31.89	$73,538.34	75,229
8/29/2023	Sell	202	$35.21	$7,112.42	79,535
3/15/2023	Sell	21	$30.11	$632.31	79,737
3/13/2023	Sell	682	$29.86	$20,364.52	82,427
3/3/2023	Sell	20,000	$33.98	$679,600.00	83,109
2/27/2023	Sell	4,315	$33.53	$144,681.95	51,375
2/13/2023	Sell	942	$33.92	$31,952.64	55,690
2/2/2023	Sell	1,947	$35.90	$69,897.30	56,632
8/30/2022	Sell	171	$29.65	$5,070.15	58,579
3/15/2022	Sell	3,678	$49.29	$181,288.62
3/11/2022	Sell	376	$54.69	$20,563.44
2/25/2022	Sell	2,221	$50.48	$112,116.08

David T. Doherty Buying and Selling Activity at Surgery Partners

Surgery Partners Company Overview

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Today's Range

Now: $25.50

$24.88

$25.76

50 Day Range

MA: $28.88

$23.42

$34.70

2 Week Range

Now: $25.50

$22.05

$45.79

Volume

1,179,018 shs

Average Volume

754,871 shs

Market Capitalization

$3.23 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.71

Global crypto currency reset (41 major banks signed up)

From Stansberry Research | Ad

Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...

Here's everything you need to know.

David Doherty Biography and Net Worth

What is David T. Doherty's net worth?

How old is David T. Doherty?

What is David T. Doherty's salary?

How do I contact David T. Doherty?

Has David T. Doherty been buying or selling shares of Surgery Partners?

Who are Surgery Partners' active insiders?

Are insiders buying or selling shares of Surgery Partners?